Skip Navigation
American College of Physicians Logo
  • Subscribe
  • Submit a Manuscript
  • Sign In
    Sign in below to access your subscription for full content
    INDIVIDUAL SIGN IN
    Sign In|Set Up Account
    You will be directed to acponline.org to register and create your Annals account
    INSTITUTIONAL SIGN IN
    Open Athens|Shibboleth|Log In
    Annals of Internal Medicine
    SUBSCRIBE
    Subscribe to Annals of Internal Medicine.
    You will be directed to acponline.org to complete your purchase.
Annals of Internal Medicine Logo Menu
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives
  • Author Info
Advanced Search
  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Summaries for Patients |3 December 2002

Screening for Prostate Cancer: A Recommendation from the U.S. Preventive Services Task Force

  • ‹ PREV ARTICLE
  • This Issue
  • NEXT ARTICLE ›
Jump To
  • Full Article
  • FULL ARTICLE
  • FULL ARTICLE
    • What is the U.S. Preventive Services Task Force?
    • What is the problem and what is known about it so far?
    • How did the USPSTF develop these recommendations?
    • What did the authors find?
    • What does the USPSTF suggest that patients do?
    • What are the cautions related to these recommendations?
  • Figures
  • Tables
  • Supplements
  • Audio/Video
  • Summary for Patients
  • Clinical Slide Sets
  • CME / MOC
  • Comments
  • Twitter Link
  • Facebook Link
  • Email Link
More
  • LinkedIn Link

What is the U.S. Preventive Services Task Force?

The U.S. Preventive Services Task Force (USPSTF) is a group of health experts that reviews published research and makes recommendations about preventive health care.

What is the problem and what is known about it so far?

The prostate gland is an organ surrounding the tube that empties urine from the bladder. Its function is to add fluid and nutrients to semen, the fluid that carries sperm. Prostate cancer is the most common type of cancer and the second most common cause of cancer-related death in U.S. men. However, prostate cancer often grows slowly and never causes a problem.
Digital rectal examination (DRE) and prostate-specific antigen (PSA) tests can find prostate cancer early, before symptoms develop. In DRE, a doctor inserts a finger into the patient's rectum to feel the prostate. A PSA test is a blood test. Very high PSA levels occur only with prostate cancer, but the more common intermediate levels also occur with benign prostate disease. Abnormal results on DRE or high PSA levels require prostate biopsy to see whether cancer is actually present. To perform the biopsy, doctors insert a hollow needle to obtain a piece of the prostate gland that can be examined under a microscope.
It is not known whether detection and treatment before symptoms develop are helpful to patients. In most cases, prostate cancer grows very slowly, so most men with early prostate cancer die of something else rather than of prostate cancer itself. Early detection, however, puts men at risk for unnecessary worry and side effects of treatment. Surgery and radiation therapy, common treatments for prostate cancer, can cause impotence and urinary leakage.

How did the USPSTF develop these recommendations?

The USPSTF reviewed published research to measure the benefits and harms of screening for prostate cancer.

What did the authors find?

The USPSTF found good evidence that PSA testing can find early prostate cancer. The evidence suggests that PSA testing correctly identifies more men with prostate cancer than DRE. However, no good-quality evidence shows that finding prostate cancer early means that fewer men die of the disease. Men most likely to benefit if screening is effective are those who are 50 to 70 years of age and those who are older than 45 years of age and at higher risk for prostate cancer because they are African American or because they have a father or brother with prostate cancer.

What does the USPSTF suggest that patients do?

The USPSTF does not recommend for or against routine screening for prostate cancer using DRE or PSA testing. Men who are interested in screening for prostate cancer should discuss it with their doctors and, most important, should not be screened without first understanding the potential benefits and harms of early treatment.

What are the cautions related to these recommendations?

As better information about the positive and negative effects of early detection and treatment of prostate cancer becomes available, the USPSTF may revisit this issue.

This feature is available only to Registered Users

Subscribe/Learn More
Submit a Comment

0 Comments

PDF
Not Available
Citations
Citation

Screening for Prostate Cancer: A Recommendation from the U.S. Preventive Services Task Force. Ann Intern Med. 2002;137:I–48. doi: https://doi.org/10.7326/0003-4819-137-11-200212030-00005

Download citation file:

  • Ris (Zotero)
  • EndNote
  • BibTex
  • Medlars
  • ProCite
  • RefWorks
  • Reference Manager

© 2020

×
Permissions

Published: Ann Intern Med. 2002;137(11):I-48.

DOI: 10.7326/0003-4819-137-11-200212030-00005

0 Citations
Advertisement

See Also
Screening for Prostate Cancer: Recommendation and Rationale
Screening for Prostate Cancer: An Update of the Evidence for the U.S. Preventive Services Task Force
View MoreView Less

Related Articles
What the U.S. Preventive Services Task Force Missed in Its Prostate Cancer Screening Recommendation
Annals of Internal Medicine; 157 (2): 137-138
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine; 157 (2): I-44
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Annals of Internal Medicine; 155 (11): 762-771
Screening for Prostate Cancer with Prostate-Specific Antigen Testing: U.S. Preventive Services Task Force Recommendations
Annals of Internal Medicine; 149 (3): I-37
View MoreView Less

Journal Club
Review: Prostate cancer screening using PSA does not decrease mortality
Annals of Internal Medicine; 154 (2): JC1-2
Annual screening for prostate cancer did not reduce mortality from prostate cancer
Annals of Internal Medicine; 150 (12): JC6-4
View MoreView Less

Related Topics
Cancer Screening/Prevention
Hematology/Oncology
Prevention/Screening
Prostate Cancer

Cancer Screening/Prevention, Hematology/Oncology, Prevention/Screening, Prostate Cancer.

PubMed Articles
Prevalence, Mortality, and Cause of Death in Charcot-Marie-Tooth Disease in Korea: A Nationwide, Population-Based Study.
Neuroepidemiology 2020.
Gender Differences in Inflammatory Bowel Disease.
Digestion 2020.
View More

Results provided by: PubMed

Advertisement
CME/MOC Activity Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
The Comments Feature Requires Users to be Registered and Logged In.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
link to top

Content

  • Home
  • Latest
  • Issues
  • Channels
  • CME/MOC
  • In the Clinic
  • Journal Club
  • Web Exclusives

Information For

  • Author Info
  • Reviewers
  • Press
  • Readers
  • Institutions / Libraries / Agencies
  • Advertisers

Services

  • Subscribe
  • Renew
  • Alerts
  • Current Issue RSS
  • Latest RSS
  • In the Clinic RSS
  • Reprints & Permissions
  • Contact Us
  • Help
  • About Annals
  • About Mobile
  • Patient Information
  • Teaching Tools
  • Annals in the News
  • Share Your Feedback

Awards and Cover

  • Personae (Cover Photo)
  • Junior Investigator Awards
  • Poetry Prize

Other Resources

  • ACP Online
  • Career Connection
  • ACP Advocate Blog
  • ACP Journal Wise

Follow Annals On

  • Twitter Link
  • Facebook Link
acp link acp
silverchair link silverchair

Copyright © 2020 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
INSTITUTIONAL SIGN IN
Open Athens|Shibboleth|Log In
Annals of Internal Medicine
PURCHASE OPTIONS
Buy This Article|Subscribe
You will be redirected to acponline.org to sign-in to Annals to complete your purchase.
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Sign in below to access your subscription for full content
INDIVIDUAL SIGN IN
Sign In|Set Up Account
You will be directed to acponline.org to register and create your Annals account
Annals of Internal Medicine
CREATE YOUR FREE ACCOUNT
Create Your Free Account|Why?
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×